Alpha Tau to Present at J.P. Morgan Healthcare Conference

Pick the best stocks and maximize your portfolio:

An update from Alpha Tau Medical Ltd ( (DRTS) ) is now available.

Alpha Tau Medical Ltd. announced that its CEO and CFO will present a corporate overview at the J.P. Morgan 43rd Annual Healthcare Conference in January 2025. This presentation will highlight recent achievements and future data milestones, potentially impacting investor interest and the company’s market positioning.

More about Alpha Tau Medical Ltd

Alpha Tau Medical Ltd. is an Israeli oncology therapeutics company established in 2016, focusing on the research, development, and potential commercialization of Alpha DaRT, a novel alpha-radiation therapy designed for the treatment of solid tumors. The technology was developed at Tel Aviv University and aims to provide targeted tumor destruction while minimizing damage to surrounding healthy tissue.

YTD Price Performance: 0.66%

Average Trading Volume: 35,324

Technical Sentiment Consensus Rating: Sell

Current Market Cap: $211.9M

For detailed information about DRTS stock, go to TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.